Literature DB >> 12481711

MDR and MRP gene families as cellular determinant factors for resistance to clinical anticancer agents.

Lei Deng1, Shigaru Tatebe, Yen-Chiu Lin-Lee, Toshihisa Ishikawa, M Tien Kuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12481711     DOI： 10.1007/978-1-4615-1173-1_3

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  5 in total

1.  Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages.

Authors:  Jean-Michel Michot; Marie F Heremans; Nancy E Caceres; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 2.  Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics.

Authors:  Maria Grazia Ferraro; Marialuisa Piccolo; Gabriella Misso; Rita Santamaria; Carlo Irace
Journal:  Pharmaceutics       Date:  2022-04-28       Impact factor: 6.525

3.  CIAPIN1 gene silencing enhances chemosensitivity in a drug-resistant animal model in vivo.

Authors:  X M Wang; S J Gao; X F Guo; W J Sun; Z Q Yan; W X Wang; Y Q Xu; D Lu
Journal:  Braz J Med Biol Res       Date:  2014-03-21       Impact factor: 2.590

4.  Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers.

Authors:  Chun Hei Antonio Cheung; Huang-Hui Chen; Ching-Chuan Kuo; Chi-Yen Chang; Mohane S Coumar; Hsing-Pang Hsieh; Jang-Yang Chang
Journal:  Mol Cancer       Date:  2009-07-03       Impact factor: 27.401

Review 5.  Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects.

Authors:  Salman Ahmed; Haroon Khan; Michael Aschner; Hamed Mirzae; Esra Küpeli Akkol; Raffaele Capasso
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.